Impact of a third dose of measles-mumps-rubella vaccine on a mumps outbreak

Pediatrics

Volumn 130, Issue 6, 2012, Pages

  Ogbuanu, Ikechukwu U ^a,b   Kutty, Preeta K ^b   Hudson, Jean M ^c   Blog, Debra ^d   Abedi, Glen R ^b   Goodell, Stephen ^c   Lawler, Jacqueline ^c   McLean, Huong Q ^b   Pollock, Lynn ^d   Rausch Phung, Elizabeth ^d   Schulte, Cynthia ^d   Valure, Barbara ^c   Armstrong, Gregory L ^b   Gallagher, Kathleen ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c Orange County Health Department   (United States)

^d NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

Measles mumps rubella (MMR) vaccine; Mumps; Outbreak; Third dose

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; AGE DISTRIBUTION; ARTHRALGIA; ARTICLE; CHILD; DRUG TOLERABILITY; EPIDEMIC; FEMALE; HUMAN; INFECTION CONTROL; INFECTION RATE; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALE; MEASLES VACCINATION; MUMPS; MYALGIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; AGE FACTORS; CHILD; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; NEW YORK; TREATMENT OUTCOME;

EID: 84870542026     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-0177     Document Type: Article

References (30)

1. Hirsch A. Mumps (Parotitis epidemica s. polymorpha). In: Handbook of Geographical and Historical Pathology. Volume III. London, UK: The New Sydenham Society; 1886:277-283
2. Center for Disease Control and Prevention. Mumps vaccine. Recommendation of Public Health Service Advisory Committee on Immunization Practices. Morbid Mortal Wkly Rep. 1977;26(48):393-394
3. Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: a historical perspective on unexpected elements. Vaccine. 2009;27(44):6186-6195
4. Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L; Centers for Disease Control and Prevention. Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1998;47(RR-8):1-57
5. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among children aged 19- 35 months - United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(36):1171-1177
6. Centers for Disease Control and Prevention. National Immunization Survey. Available at: www.cdc.gov/vaccines/statssurv/nis/default.htm#nis. Accessed September 18, 2012
7. Centers for Disease Control and Prevention. National Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2006. MMWR. 2007;56(34): 885-888. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/mm5634a3.htm?s-cid= mm5634a3-e. Accessed September 18, 2012
8. Dayan GH, Quinlisk MP, Parker AA, et al. Recent resurgence of mumps in the United States. N Engl J Med. 2008;358(15):1580-1589 (Pubitemid 351519818)
9. Centers for Disease Control and Prevention (CDC). Summary of notifiable diseases: United States, 2009. MMWR Morb Mortal Wkly Rep. 2011;58(53):1-100
10. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2008. MMWR Morb Mortal Wkly Rep. 2009;58(36):997-1001
11. Barskey AE, Schulte C, Rosen JB, et al. Mumps Outbreak among Orthodox Jewish Communities in the United States. NEJM. In press
12. United States Census Bureau. American Community Survey 5-year estimates. Available at: http://factfinder.census.gov/main.html. Accessed September 18, 2012
13. United States Census Bureau. 2010 Population estimates. Available at: http://factfinder2.census.gov/main.html. Accessed October 7, 2011
14. Centers for Disease Control and Prevention. Comprehensive Clinic Assessment Software Application (CoCASA). Available at: www.cdc.gov/vaccines/ programs/cocasa/default.htm. Accessed October 8, 2011
15. Department of Health. New York State. New York codes, rules and regulations, Title 10. Available at: www.health.ny.gov/regulations/nycrr/title- 10/. Accessed September 18, 2012
16. Council of State and Territorial Epidemiologists. Revision of the Surveillance Case Definition for Mumps. 2007. Available at: www.cste.org/dnn/ AnnualConference/PositionStatements/tabid/191/Default.aspx. Accessed September 18, 2012
17. Brockhoff HJ, Mollema L, Sonder GJ, et al. Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine. 2010;28(17):2932-2936
18. Abedi GR, Mutuc JD, Lawler J et al. Adverse Events Following a Third Dose of Measles, Mumps, and Rubella Vaccine in a Mumps Outbreak. Vaccine. 2012, In press.
19. Whelan J, van Binnendijk R, Greenland K, et al. Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill. 2010;15(17):19554
20. Stein-Zamir C, Shoob H, Abramson N, Tallen-Gozani E, Sokolov I, Zentner G. Mumps outbreak in Jerusalem affecting mainly male adolescents. Euro Surveill. 2009;14 (50):19440
21. Wharton M, Cochi SL, Hutcheson RH, Bistowish JM, Schaffner W. A large outbreak of mumps in the postvaccine era. J Infect Dis. 1988;158 (6):1253-1260 (Pubitemid 19023289)
22. Deeks SL, Lim GH, Simpson MA, et al. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ. 2011;183(9):1014-1020
23. McLean H, Hickman C, Seward J. Module 16: Mumps. The Immunological Basis for Immunization Series. Geneva, Switzerland: World Health Organization; 2010. Available at: http://whqlibdoc.who.int/publications/2010/9789241500661-eng.pdf. Accessed September 18, 2012
24. Marin M, Nguyen HQ, Langidrik JR, et al. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy. Clin Infect Dis. 2006;42(3):315-319 (Pubitemid 43122303)
25. Dayan GH, Rubin S. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Clin Infect Dis. 2008;47(11):1458-1467
26. Hviid A, Rubin S, Mühlemann K. Mumps. Lancet. 2008;371(9616):932-944 (Pubitemid 351375277)
27. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students - Iowa, 2006. Vaccine. 2008;26(29-30):3601-3607
28. Centers for Disease Control and Prevention (CDC). Measles outbreak - Southwestern Utah, 1996. MMWR Morb Mortal Wkly Rep. 1997;46(33):766-769
29. Yeung LF, Lurie P, Dayan G, et al. A limited measles outbreak in a highly vaccinated US boarding school. Pediatrics. 2005;116(6):1287-1291 (Pubitemid 46056473)
30. Date AA, Kyaw MH, Rue AM, et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis. 2008;197(12):1662-1668 (Pubitemid 351919629)